3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
6
Motor Activity
5
Neoplasm Metastasis
3
Fatigue
3
Depression
3
Neoplasms
2
Lymphedema
2
Breast Cancer Lymphedema
2
Anxiety Disorders
2
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Neurotoxicity Syndromes
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Kinesiophobia
1
Head and Neck Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Bone Neoplasms
1
Body Weight Changes
1
Arthritis
1
Accessory Nerve Injuries
1
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Exercise Therapy
×
Clear all
NCT04963517
2024-12-06
proGAIT
Universität Duisburg-Essen
Phase 2/3
Completed
11 enrolled